Video

Top 15 Definition as per USP

Ipca Laboratories Indore USFDA 483 Observations

Review INTAS PHARMA || USFDA 483 Observations ||May 2023 ||

Top 10 HPLC Interview Questions and Answers || For Freshers ||

Review of Intas Pharma IMPORT ALERT 2023

Review || IPCA Laboratories || USFDA 483 Observations || Pipria Plant ||

Cipla Indore USFDA 483 Observations

Top 20 Stability section Interview QUESTION & ANSWERS || Part-1 ||

Form 483 Download link www.fda.gov/media/164243/download Warning letter link www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glenmark-pharmaceuticals-limited-637314-11222022

INTAS Form 483 Download link: www.fda.gov/media/164602/download

Pharma Updates of Entire Year 2022

GMP UPDATES 00:00 Introduction 00:49 Update 1 : USP 232 Elemental impurities draft published. 01:52 Update 2 : Draft published for Bioequivalence studies. 02:43 Update 3: Glenmark Goa got warning letter from USFDA. 04:34 FDA issued form 483s to Aurobindo & Lupin in December. 05:22 Update 5: Import alert to Sun Pharma Halol Plant. 06:01 Update 6: Lupin Recalls Quinapril tablets 4 lots

ICH Q2 R1 || Analytical Method Validation || Identification test by IR ||

Aurobindo Pharma Unit-9 Form 483 observations.

GMP Updates || November 2022 ||

Biocon Malaysia USFDA 483 observations

Jubilant Generics || Dehradoon ||USFDA 483 Observations || August 2022 ||

Working Principle of Analytical Balance ||European pharmacopeia General Chapter 2.1.7 || Part-1 ||

GMP Updates of October 2022

Torrent Pharma 483 Observations

Biocon Ltd Bengaluru 483 Observations || USFDA || August 2022 ||

GMP Updates of September 2022

Aurobindo Pharma Unit-11 USFDA 483 Observations August 2022

Cipla Goa USFDA 483 Observations

GMP Updates of August 2022

Sun Pharma Mohali || USFDA 483 Observations || August 2022 ||

Types of QC Balances

Top 20 Interview Questions & Answers || Analytical Balances ||

USP General Chapter 1251 || Weighing on analytical balance || Part-3 ||